India tells states to ramp up COVID-19 emergency procedures
HQ Team April 8, 2023: India’s federal government has told state authorities to identify emergency COVID-19 hotspots and ramp up testing, vaccination, and.
Bharti Rana Jayshankar – Founder
She brings in more than 30 years of experience in content building, architecture, writing, editing and storytelling. Ms Jayshankar has worked in the Economic Times daily, IBT Times, Investopedia and more than a dozen content firms as a content strategist and planner.
Jay Shankar – Co-founder
He has almost three decades of experience in journalism. He has worked with national dailies such as ET, Indian Express, The Pioneer, The Hindu, Agence France Presse and Bloomberg.
HQ Team April 8, 2023: India’s federal government has told state authorities to identify emergency COVID-19 hotspots and ramp up testing, vaccination, and.
HQ Team April 7, 2023: The FDA has withdrawn Netherland-based Covis Pharma’s drug meant to cut preterm birth as it failed to prove.
H.Q. Team April 7, 2023: Dr. Reddy’s Laboratories, an Indian maker of generics and active pharmaceutical ingredients, has completed the acquisition of Mayne.
HQ Team April 6, 2023: Dengue viral infection has increased from 505,430 cases in 2000 to 5.2 million in 2019, and its spread.
HQ Team April 5, 2023: Arbutus Biopharma Corporation and Genevant Sciences filed a lawsuit in a US court seeking compensation for Pfizer and BioNTech’s unlicensed use.
HQ Team April 5, 2023: Johnson and Johnson, a US multinational making pharmaceuticals and medical devices, has offered to pay $8.9 billion to.
HQ Team April 4, 2023: About one in six people worldwide suffer from infertility, a disease that disables the male or female reproductive.
HQ Team April 3, 2023: BioNTech SE and Duality Biologics (Suzhou) have signed a $1.5 billion deal to develop and commercialise two cancer.
The CDC laboratory testing identified the presence of the outbreak strain in opened EzriCare bottles with different lot numbers collected from two states.
India has granted a complete customs duty exemption for the personal use of medicines to treat rare diseases, including Merc & Co’s Keytruda.
We use cookies to improve your experience on our site. By using our site, you consent to cookies.
Manage your cookie preferences below:
Essential cookies enable basic functions and are necessary for the proper function of the website.
Statistics cookies collect information anonymously. This information helps us understand how visitors use our website.
Google Analytics is a powerful tool that tracks and analyzes website traffic for informed marketing decisions.
Service URL: policies.google.com